Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FCNAB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29.7K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026 under the SPE2DB program, which enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's contract portfolio demonstrates expertise across diverse therapeutic categories including oncology treatments, immunosuppressants, and specialty medications. As a registered woman-owned small business since 2001, DMS Pharmaceutical Group leverages its SAM.gov registration and established relationships with the Defense Logistics Agency to compete effectively in federal procurement markets, positioning itself as a reliable distributor of FDA-approved pharmaceutical products to government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FCNAB?
SPE2DB25FCNAB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FCNAB worth?
The government has obligated $29,670 on SPE2DB25FCNAB.
Is contract SPE2DB25FCNAB an order under another contract?
Yes. SPE2DB25FCNAB is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAB competed?
The extent of competition for SPE2DB25FCNAB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award